All Or Nothing: Paratek Withdraws EU Filing For Nuzyra
Drug Is Approved In US And Was In Final Stages Of EMA Review
A month after being asked to attend an oral explanation meeting with the European Medicines Agency, Paratek Pharmaceuticals has decided to withdraw the EU marketing application for its broad spectrum antibiotic, Nuzyra. The company is one of two drug sponsors that has withdrawn an EU marketing application in October.
